An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers.
Latest Science News — ScienceDaily
Intranasal flu vaccine with nanoparticles offers robust protection
January 29, 2022By
What is an EUA, and what does it have to do with how quickly we get a coronavirus vaccine?
January 23, 2022By
With talk of the possible availability of a vaccine candidate heating up, you might have heard the term Emergency Use Authorization — or EUA — all over the news lately. But what is it exactly, and how does it apply to vaccines?
Here’s why a vaccine will not stop the Covid-19 pandemic right away
December 24, 2021By
Dr. Umair Shah remembers the last mass vaccination campaign the US waged.
NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial
December 6, 2021By
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.
Most Americans probably won’t be able to get a Covid-19 vaccine until mid-2021, CDC director says
November 19, 2021By
A wedding in Maine is linked to 176 Covid-19 cases and the deaths of seven people who didn’t attend the celebration, demonstrating just how easily and quickly the virus can spread at social gatherings, public health experts say.
Oregon: CDC investigating woman’s death after J&J vaccine
April 23, 2021By
Oregon health authorities say federal officials are investigating the death of a woman in her 50s who developed a blood clot and low platelets within two weeks of receiving the Johnson & Johnson COVID-19 vaccine
ABC News: Top Stories
First images of cells exposed to COVID-19 vaccine reveal native-like Coronavirus spikes
April 8, 2021By
New research has for the first time compared images of the protein spikes that develop on the surface of cells exposed to the Oxford-AstraZeneca vaccine to the protein spike of the SARS-CoV-19 coronavirus.
Newswise: Latest News
One of the leading coronavirus vaccine trials is currently paused. Prominent vaccine researchers tell CNN that’s unusual
February 6, 2021By
Vaccine clinical trials are notoriously difficult to conduct.
AstraZeneca’s Oxford vaccine trial to resume, the university says
February 3, 2021By
The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday.
Why some older people are getting the vaccine in Southern California but others are striking out
January 17, 2021By
Many Californians 65 and older faced frustration and confusion as they tried to get the coronavirus vaccine after the state announced it was opening up vaccinations to older people.
